Elsamitrucin

· Spectrum Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Elsamitrucin, covering 2008-01-15 to 2008-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]